FDA Grants Accelerated Approval for QALSODY (tofersen) for SOD1-ALS, a Major
FDA Grants Accelerated Approval for QALSODY™ (tofersen) for SOD1-ALS, a Major Scientific Advancement as the First Treatment to Target a Genetic Cause of ALS | Biogen BiogenFDA grants accelerated approval for Biogen ALS drug that treats…